Safety of vonoprazan in pregnant women study
Treatments studied
Part of Digestive system, Infections, Women’s health & pregnancy clinical trials.
This study looks at the safety of vonoprazan (a medicine for acid reflux) when taken during pregnancy. It follows pregnant women who took the drug and those who didn't, to see how it affects mothers and their babies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 15 and 50 years old.
- You are currently pregnant or have been pregnant recently.
- You agree to take part in the study and allow your healthcare provider to share your medical records.
- Either you took vonoprazan during pregnancy (exposed group) or you have a condition that vonoprazan is used to treat but did not take it (unexposed group).
- You have not been exposed to known harmful medications or experimental drugs during this pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called vonoprazan to see if it can reduce episodes of heartburn in people who have GERD but no damage to their esophagus. It compares the medicine to a placebo (a pill with no active ingredient) over 24 weeks.
This trial compares two medicines—vonoprazan and esomeprazole—to see which is better at healing acid damage to the esophagus (erosive esophagitis). If you have had heartburn and an endoscopy confirmed inflammation, you may be eligible for this study.
This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.
This study tests a new antibiotic combination to treat stomach infections caused by H. pylori bacteria. It may help clear the infection and reduce stomach problems.
This trial compares a newer drug (vonoprazan) plus antibiotics to the standard triple therapy for eradicating H. pylori infection in the stomach. It may be a good option if you have stomach symptoms like indigestion, acid reflux, or a non-bleeding ulcer and have not been treated for H. pylori before.
This trial tests a medicine called vonoprazan for people whose acid reflux symptoms (like heartburn or coughing) don't get better with usual treatment. It aims to see if vonoprazan can help control those symptoms.
Hear when a new Erosive Esophagitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.